Patrick F. Franken
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability Tradeoffs.
Journal: Molecular cancer therapeutics
Published: January 13, 2026
Enapotamab Vedotin, an AXL-Specific Antibody-Drug Conjugate, Demonstrates Antitumor Efficacy in Patient-Derived Xenograft Models of Soft Tissue Sarcoma.
Journal: International journal of molecular sciences
Published: May 30, 2022
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade.
Journal: Cancer research
Published: February 05, 2020
The role of S100a4 (Mts1) in Apc- and Smad4-driven tumour onset and progression.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 30, 2016
Secreted Phospholipases A2 Are Intestinal Stem Cell Niche Factors with Distinct Roles in Homeostasis, Inflammation, and Cancer.
Journal: Cell stem cell
Published: August 31, 2015
Cancer stemness in Wnt-driven mammary tumorigenesis.
Journal: Carcinogenesis
Published: August 20, 2013
Cancer stemness in Apc- vs. Apc/KRAS-driven intestinal tumorigenesis.
Journal: PloS one
Published: March 08, 2013
Alterations in Wnt-β-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression.
Journal: The Journal of pathology
Published: October 28, 2012
β-Catenin signaling dosage dictates tissue-specific tumor predisposition in Apc-driven cancer.
Journal: Oncogene
Published: May 09, 2012
Last Updated: 09/26/2026